Table 3.
Association Between Patient‐Reported CRS Control Level and CRS Disease Characteristics
| Univariate analysis | Multivariable analysisa | |||
|---|---|---|---|---|
| RRb (95% CI) | P value | RRb (95% CI) | P value | |
| SNOT‐22 score | 0.99 (0.98–0.99) | < 0.001 | 0.99 (0.98–0.99) | <.001 |
| Number of sinus infection in last 3 months | 0.81 (0.73–0.91) | < 0.001 | — | — |
| Number of CRS‐related antibiotics in last 3 months | 0.86 (0.77–0.95) | 0.003 | 0.94 (0.84–1.05) | .294 |
| Number of CRS‐related oral corticosteroids in last 3 months | 0.91 (0.81–1.02) | 0.116 | 1.04 (0.92–1.18) | .493 |
| Number of days of missed work or school due to CRS in last 3 months | 0.99 (0.98–1.01) | 0.240 | 1.00 (0.99–1.01) | .986 |
a
Including SNOT‐22 score, number of CRS‐related antibiotics, number of CRS‐related oral corticosteroids and missed days of work or school due to CRS as independent variables.
b
Relative risk